Finally, several genes in the [NASH]vs[NAFLD + HC] signature (e.g. CHST9, DPYSL2) have not been previously implicated in liver disease and could potentially provide novel biological insights into NASH etiology. This evidence concerns the gene DPYSL2 and metabolic dysfunction-associated steatohepatitis.